
|Videos|April 29, 2022
Improving vaccination rates in high-risk groups
Author(s)Miranda Hester
A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.
Advertisement
Anthony W. Gannon, MD, a pediatric endocrinilogist at Nemours Children's in Wilmington, Delaware, sat down with Contemporary Pediatrics to discuss a poster presented at the 2022 Pediatric Academic Societies meeting that examined the impact of a quality improvement program on improving 23-valent pneumococcal polysaccharide vaccine uptake in 3 groups that are at high risk. He shared the ins and outs of the research, how other health systems could consider a similar project, and what the next steps are.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recent advances in the treatment of molluscum contagiosum
2
FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older
3
FDA grants priority review to Tivicay PD for neonatal HIV
4
Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age
5



